Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. INTC
2. AMZN
3. COIN
4. RDDT
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 6c

Adaptive Biotechnologies Reports Third Quarter 2022 Financial Results

November 3, 2022 4:06 PM EDT

SEATTLE, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Adaptive Biotechnologies) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended September 30, 2022.

We continue to deliver solid growth in both of our business areas quarter over quarter, and are confident in our long-term outlook, said Chad Robins, chief executive officer and co-founder of Adaptive Biotechnologies. With a bolstered cash position from our recent financing, we are focused on driving growth and... More